Optogenetic Therapy Shows Efficacy in Autosomal Recessive Retinitis Pigmentosa

Results from a phase 1/2 study from Nanoscope Therapeutics were presented at the 2021 ASRS meeting.

GeneTherapyLive’s Weekly Rewind – October 15, 2021

Review top news and interview highlights from the week ending October 15, 2021.

Cell Therapy a Promising Option in Corneal Endothelial Disease

The cell therapy yielded improvements in visual acuity and central corneal thickness.